Aspiriant LLC has decreased its holdings in Intel Co. shares by 1.6% during the first quarter, selling 439 shares and leaving them with 26,224 shares valued at $1,158,000. Other institutional investors, such as Barrett & Company Inc., Revolve Wealth Partners LLC, New Millennium Group LLC, Waldron Private Wealth LLC, and Spreng Capital Management Inc., have also made adjustments to their positions in the company. CEO Patrick Gelsinger purchased 4,100 shares of Intel’s stock in a recent transaction. Wall Street analysts have provided varying ratings and price targets for Intel, with a consensus rating of “Hold” and an average price target of $39.58.
Intel shares saw a 0.2% increase, opening at $30.59 on Friday, with a market capitalization of $130.22 billion. The company’s financial performance for the last quarter showed earnings per share of ($0.06), slightly below analysts’ expectations. Additionally, the company declared a quarterly dividend of $0.125 per share, paid on June 1st, with an annualized dividend of $0.50 and a dividend yield of 1.63%.
Intel Corporation is a global technology company that designs, manufactures, and sells computing products and services. Its segments include Client Computing Group, Data Center and AI, Network and Edge, Mobileye, and Intel Foundry Services. The company’s product portfolio includes CPUs, chipsets, SoCs, GPUs, FPGAs, memory and storage products, and more.
Featured articles and charts related to Intel’s institutional ownership and performance are also provided on the MarketBeat website. Readers can sign up for daily email newsletters to stay updated on the latest news and analyst ratings for Intel and other related companies.
Article Source
https://www.defenseworld.net/2024/06/28/aspiriant-llc-reduces-stock-position-in-intel-co-nasdaqintc.html
